0001209191-23-039157.txt : 20230622
0001209191-23-039157.hdr.sgml : 20230622
20230622183229
ACCESSION NUMBER: 0001209191-23-039157
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230622
DATE AS OF CHANGE: 20230622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wettig Thane
CENTRAL INDEX KEY: 0001815638
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 231034498
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0407
4/A
2023-06-07
2023-06-09
0
0000921299
FIBROGEN INC
FGEN
0001815638
Wettig Thane
C/O FIBROGEN, INC.
409 ILLINOIS STREET
SAN FRANCISCO
CA
94158
0
1
0
0
Chief Commercial Officer
0
Common Stock
2023-06-07
4
S
0
472
17.0356
D
110338
D
Common Stock
2023-06-07
4
S
0
1286
17.0377
D
109052
D
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
Includes 2,500 shares acquired on May 15, 2023 through the Issuer's Employee Stock Purchase Plan.
This amendment to Form 4 is being filed solely to correct an inadvertent math error contained in the end of period holdings in Box 5 of the Form 4 filed on June 9, 2023.
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
2023-06-22